Medopad rebrands as Huma, acquires BioBeats and TLT to expand its biomarker platform
Image Credits: Busakorn Pongparnit (opens in a new window)/ Getty Images Some big changes are underway for London-based Medopad, a startup that builds software for medical practitioners to monitor patients remotely based on digital biomarkers — measurable indicators of the progression of illnesses, diseases or overall health that are picked up not with blood samples or in-doctor visits but using … Continue reading Medopad rebrands as Huma, acquires BioBeats and TLT to expand its biomarker platform Continue Reading

